Fresenius Medical Care Sees US Plans for Kidney Disease as Positive
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Power your practice with our resources. We're here to help support your patients and your thriving practice.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Fresenius Renal Pharmaceuticals is dedicated to providing pharmaceuticals services to the more than 400,000 individuals undergoing dialysis throughout the United States.
Our team is passionately committed to helping people living with end stage renal disease (ESRD) lead more active and fulfilling lives by supporting care both in center and at home. That's why we've become the partner of choice for biotech and pharmaceutical companies providing treatment to ESRD patients.
© 2015, 2017, 2019, Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, Fresenius Renal Pharmaceuticals, the triangle logo, PhosLo, and Phoslyra are trademarks of Fresenius Medical Care Holdings, Inc and/or its affiliated companies. All other trademarks are the property of their respective owners. Phoslyra is manufactured for Fresenius Medical Care North America. PhosLo is manufactured for Fresenius Medical Care North America. Venofer is manufactured under license from Vifor (International) Inc., Switzerland and American Regent, Inc. Shirley, NY. Velphoro is made in Switzerland and distributed by Fresenius Medical Care North America. P/N 102763-02 Rev C 06/2019